TITLE

Prevention of Atheromatous Heart Disease

AUTHOR(S)
Agarwal, O.P.
PUB. DATE
August 1985
SOURCE
Angiology;Aug1985, Vol. 36 Issue 8, p485
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Five thousand patients of atheromatous heart disease, presented as angina pectoris, were studied over a period of five years. After adding the ‘Husk of Isabgol’ and ‘aloe vera’ (an indigenous plant known as ghee-guar-ka-paththa) to the diet, a marked reduction in total serum cholesterol, serum triglycerides, fasting and post parandial blood sugar level in diabetic patients, total lipids and also increase in HDL were noted. Simultaneously the clinical profile of these patients showed reduction in the frequency of anginal attacks and gradually, the drugs, like verapamil, nifedipine, beta-blockers and nitrates, were tapered. The patients, most benefitted, were diabetics (without adding any antidiabetic drug). The exact mechanism of the action of the above two substances is not known, but it appears, that probably they act by their high fibre contents. Both these substances need further evaluation. The most interesting aspect of the study was that no untoward side effect was noted and all the five thousand patients are surviving till date.
ACCESSION #
16352087

 

Related Articles

  • Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Hjemdahl, P.; Eriksson, S. V.; Held, C.; Forslund, L.; Näsman, P.; Rehnqvist, N. // Heart;Feb2006, Vol. 92 Issue 2, p177 

    Objective: To evaluate the long term prognosis of patients with stable angina pectoris. Design: Registry based follow up (median 9.1 years) of patients participating in the APSIS (angina prognosis study in Stockholm), which was a double blind, single centre trial of antianginal drug treatment....

  • Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease. Winniford, Michael D.; Willerson, James T.; Hillis, L. David // Angiology;Aug1982, Vol. 33 Issue 8, p522 

    The so-called calcium antagonists-verapamil, nifedipine, diltiazem, and perhexiline-are pharmacologic agents that will have a dramatic impact on the medical therapy of individuals with ischemic heart disease. They have been used extensively in Europe and Japan for over 15 years, and more recent...

  • Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers. van der Vring, J. A. F. M.; Daniëls, M. C. G.; Holwerda, N. J. H.; Withagen, P. J. A. M.; Schelling, A.; Cleophas, T. J.; Hendriks, M. G. C. // Angiology;Jun1999, Vol. 50 Issue 6, p447 

    The combination of calcium channel blockers and beta blockers is more effective for the treatment of exercise-induced angina pesters than beta blocker monotherapy. Since ischemia in exercise-induced angina is essentially preceded by an increase in heart rate, calcium channel blockers with...

  • Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris: A 3-Month Randomised, Double-Blind, Multicentre, Noninferiority Trial. Ruzyllo, Witold; Tendera, Michal; Ford, Ian; Fox, Kim M. // Drugs;2007, Vol. 67 Issue 3, p393 

    Background and objective: Current medical therapies for the symptoms of angina pectoris aim to improve oxygen supply and reduce oxygen demand in the myocardium. Not all patients respond to current antianginal monotherapy, or even combination therapy, and a new class of antianginal drug that...

  • 250 Changes of coronary blood flow in vasospastic angina under cold stimulation. Park, S. M.; Shim, W. J.; Rha, S. W.; Park, S. W.; Lim, D. S.; Kim, Y. H.; Oh, D. J.; Ro, Y. M. // European Journal of Echocardiography;2003, Vol. 4 Issue suppl_1, pS128 

    An abstract of the article "Changes of coronary blood flow in vasospastic angina under cold stimulation" by S.M. Park, W.J. Shim, S.W. Rha, S.W. Park, D.S. Lim, Y.H. Kim, D.J. Oh and Y.M. Ro is presented.

  • Angeze.  // Royal Society of Medicine: Medicines;2002, p61 

    The article provides information on Angeze, a proprietary, non-prescription preparation of the drug isosorbide mononitrate. It can be used as an anti-angina drug, and is available as tablets.

  • Angina Pectoris.  // Encyclopedic Reference of Molecular Pharmacology;2004, p38 

    The article presents an encyclopedia entry for angina pectoris. It refers to a clinical syndrome caused by transient myocardial ischemia. Patients suffer from a squeezing substernal discomfort and the pain may radiate to the left shoulder and to other regions of the body. They may also suffer...

  • variant angina. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p782 

    An encyclopedia entry for "variant angina" is presented. It refers to a medical condition in which chest pain occurs when at rest, often during sleep. Variant angina, which is a form of angina pectoris, also known as Prinzmetal's angina, is accompanied by breathlessness and palpitations. The...

  • Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina. Naruko, T.; Furukawa, A.; Yunoki, K.; Komatsu, R.; Nakagawa, M.; Matsumura, Y.; Shirai, N.; Sugioka, K.; Takagi, M.; Hozumi, T.; Itoh, A.; Haze, K.; Yoshiyama, M.; Becker, A. E.; Ueda, M. // Heart;Nov2010, Vol. 96 Issue 21, p1716 

    Background Myeloperoxidase (MPO) is a leucocyte enzyme that catalyses the formation of a number of reactive oxidant species. Objective The purpose of this study is to evaluate the relationship between angiographic coronary plaque morphology in patients with unstable angina pectoris (UAP) or...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics